In Silico Drug Discovery Services Market Revenue Predicted to Go Up by 2030

B2B Forum › Category: Marketing, Advertising and PR › In Silico Drug Discovery Services Market Revenue Predicted to Go Up by 2030

0 Vote Up Vote Down

Stella Wilson asked 3 years ago

Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery timelines
Roots Analysis is pleased to announce the publication of its recent study, titled, “In Silico / Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (Antibodies, Proteins, Peptides, Nucleic Acid, Gene Therapy and Vectors), 2020-2030 (Including Structure Based Drug Discovery, Fragment Based Drug Discovery, Ligand Based Drug Discovery, Target Based Drug Discovery / Multi-Target Drug Design, Interface Based Drug Discovery, Approaches).”
The report features an extensive study on the current landscape and the likely future potential of the companies offering services for the discovery of large molecule drugs based on the use of in silico tools and techniques. The study features an in-depth analysis, highlighting the capabilities of various industry stakeholders. In addition to other elements, the report includes:

A detailed assessment of the current market landscape of companies offering in silico drug discovery services for large molecules.
Elaborate profiles of key industry players that offer a wide range of in silico drug discovery services (shortlisted on the basis of the company size).
A detailed peer group-based benchmarking analysis, comparing the involved players based on several relevant parameters related to company and services.
An insightful competitiveness analysis featuring a four-dimensional bubble chart, highlighting the key players in this domain.
A detailed analysis assessing the current opportunity within in silico drug discovery services market.
A discussion on the various business strategies that can be adopted by in silico drug discovery service providers in order to maintain a competitive edge in this industry.
An insightful analysis highlighting the cost saving potential associated with the use of in silico approaches in the drug discovery process.
A case study comparing the key challenges associated with the discovery and production of large molecules.
Insights from an industry-wide survey, featuring inputs solicited from various experts in this domain.
A discussion on the upcoming computational approaches that are being adopted for drug discovery purposes.
A case study highlighting several non-computational methods / technologies used in drug discovery process.

Get Detailed Research on:
https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Key Drug Discovery Steps

Target Identification
Target Validation
Hit Generation
Hit-to-Lead
Lead Optimization

Type of Large Molecule

Antibodies
Proteins
Peptides
Nucleic Acids
Vectors

Company Size

Small
Mid-sized
Large

Target therapeutic Area

Autoimmune Disorders
Blood Disorders
Cardiovascular Disorders
Gastrointestinal and Digestive Disorders
Hormonal Disorders
Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS)
Infectious Diseases
Metabolic Disorders
Mental Disorders
Musculoskeletal Disorders
Neurological Disorders
Oncological Disorders
Respiratory Disorders
Skin Disorders
Urogenital Disorders
Others

Type of Sponsor

Industry Players
Non-Industry Players

Key Geographical Regions

North America
Europe
Asia-Pacific

Transcripts of interviews held with the following senior level representatives of stakeholder companies

John L Kulp (Chief Executive Officer and Chief Technical Officer, Conifer Point Pharmaceuticals)
Sven Benson (Founder, candidum)
Mark Whittaker (Senior Vice President, Evotec)
Edelmiro Moman (Scientific Consultant and Teacher, ProSciens)

Key companies covered in the report